Presentation TCT 2014

In the Potent ADP Antagonist Era, Vorapaxar Will Have a Limited Role!

Presenter: Franz-Josef Neumann

September 14, 2014

REGISTER for free or LOG IN to view this content

In the Potent ADP Antagonist Era, Vorapaxar Will Have a Limited Role!

Coronary

Presentation

TCT 2014

Up Next

Presentation TCT 2014

Mitral Valve Operative Techniques: Which Make a Measurable Difference? In Which Patients?

Presenter: David H. Adams

September 14, 2014

More slides +

Presentation TCT 2014

The MitraSpacer

Presenter: Lars G. Svensson

September 14, 2014

Presentation TCT 2014

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

Presenter: Suzanne Baron

September 14, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.